| Name | Novacyt S.A. (CDI) |
|---|---|
| Epic | NCYT |
| Isin | FR0010397232 |
| Index | AIM100 AIM350 |
| Industry | Medical Equipment and Services |
| Latest share price | 56.70p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £40.05 | Debt ratio | n/a |
| Shares in issue | 70.63 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -40.4 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -39 | 52-week high / low | 43.73p / 118.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Novacyt S.A. (CDI) |
|---|---|
| Address | 13 Avenue Morane Saulnier, Ve´lizy-Villacoublay, France, 78140 |
| Telephone | +33 (0)1 39 46 51 04 |
| Website | http://novacyt.com/ |
| Director | Position |
|---|---|
| Mr Steve Gibson | CFO |
| Dr Ian David Gilham | Non-Executive Director |
| Mr Joanne Mason | Executive Director |
| Mr John Brown | Non-Executive Chairman |
| Mr Lyn Rees | Chief Executive Officer |
| Mr Jean-Pierre Crinelli | Independent Non-Executive Director |
| Ms Juliet Thompson | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 31.68 | 9.77 | 15.18 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 47.37 | 13.66 | 24.91 |
| Inventory / work in progress | 3.02 | 3.03 | 11.46 |
| Trade and other receivables | 39.36 | 37.23 | 45.57 |
| Cash and equivalents | 44.05 | 86.97 | 101.75 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 133.81 | 140.9 | 183.7 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 29.57 | 24.24 | 38.9 |
| Long term liabilities | 17.01 | 1.45 | 2.98 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 46.57 | 25.68 | 41.88 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 87.24 | 115.22 | 141.81 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 4.05 | 4.05 | 4.05 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 29.9 | 61.45 | 87.19 |
| Share premium account | 50.67 | 50.67 | 50.67 |
| Total equity | 87.24 | 115.22 | 141.81 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -29.52 | -23.39 | -3.92 |
| Pre-tax profit | -28.57 | -20.05 | -5.66 |